BDSX
Biodesix Inc
30.40$
+4.5%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.7% | +1.0% | +21.0% | +1.3% | +12.6% | -12.1% | +11.5% | +8.7% | +32.1% | -11.1% | +5.1% | – | |
| – | +4.5% | -5.9% | +22.1% | +7.8% | +3.9% | -14.7% | +8.9% | +1.9% | +18.8% | -13.8% | +14.6% | – | |
| – | +10.1% | +3.1% | +20.7% | -0.5% | +15.1% | -11.4% | +12.2% | +10.5% | +35.2% | -10.6% | +3.2% | – | |
| – | -2.5% | +8.0% | +25.4% | -0.4% | -5.2% | +18.9% | +13.9% | -8.5% | -4.1% | +14.5% | -4.6% | – | |
| – | +127.4% | -41.7% | -4.4% | +1.8% | +1.0% | +1.1% | +9.6% | -3.1% | +5.8% | +5.6% | +0.1% | – | |
| – | +4.0% | +24.9% | -1.7% | +1.2% | +0.8% | +2.6% | +10.1% | -3.8% | +4.6% | +6.6% | -0.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.4% | +8.6% | -23.4% | +5.4% | -14.2% | -3.8% | +12.6% | +9.3% | -0.7% | -4.0% | +0.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -235.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.